Save the date in your event calendar:
Join and learn about the new era of cancer care at the ICPO Theranostics Virtual
Summit, Nov 14 -15, 2024
The ICPO Foundation offers a world-class scientific program powered by academic
and industrial experts focusing on alpha emitters and new radiopharmaceuticals.
June 27, 2024 - Wiesbaden, Germany. Theranostics combines diagnostics and
therapy for precise cancer treatment. By using tailored radiopharmaceuticals,
tumors can be specifically identified and treated, with high efficacy and low
side effects. This personalized medicine is revolutionizing oncology. The ICPO
Theranostics Summit 2024 takes place on November 14 to 15, 2024, and will
feature a world-class scientific program powered by over 30 distinguished
academic and industry experts from the ICPO Community. Our focus will be to
explore innovations, from bench to bedside, first in the field of alpha
emitters, with actinium and more, then across the range of new
radiopharmaceuticals, such as FAP and beyond. Moreover, the objective will be to
sketch together the contours of a new era in cancer care, ultimately benefiting
patients around the globe.
Building on the growing success of the first edition of the ICPO Theranostics
Summit in 2022, as well as of the multiple FAP (Fibroblast Activation Protein)
sessions hosted during the ICPO Forum in 2023 and the Theranostics World
Congress earlier in 2024, the ICPO Foundation is pleased to launch its new ICPO
Theranostics Summit 2024.
Whether attendees are already very familiar with alpha emitters and new
radiopharmaceuticals or are just curious about how these latest developments
will potentially impact clinical applications in their country, the ICPO
Theranostics Summit 2024 will be very enlightening. In addition to eye-opening
talks and vibrant panel discussions, there will also be an exciting Q&A session
and a critical debate on the current and future clinical relevance of
radiotheranostics in the perspective of improved patient outcomes and better
access to more personalized, abundant and democratized cancer care.
Find the program and registration platform here: www.icpovirtualsummit.com
(http://www.icpovirtualsummit.com)
About ICPO Foundation
The International Centers for Precision Oncology Foundation (ICPO) is a non-
profit organization established in 2019 under German law by leading
international medical practitioners and life sciences entrepreneurs. Recognizing
a paradigm shift in cancer care from one size fits all to a personalized
approach, the ICPO Foundation is helping to build momentum to scale global
patient access to Radiomolecular Precision Oncology to support this shift.
Therefore, the ICPO Foundation aims to develop an international network of
physical diagnostic and therapeutic Centers for Precision Oncology organized in
a Social Franchise model based on shared know-how, certified education with the
ICPO Academy for Theranostics, and design and process standardization that
enables best clinical practice globally. Furthermore, it is the ICPO
Foundation's objective to empower its Centers by embedding them in a highly
inclusive Community that spearheads its model and lives up to the Precision
Oncology promise by making it available to all patients in need, irrespective of
country or social status.
Learn more about the ICPO Foundation at www.icpo.foundation
(http://www.icpo.foundation) and the ICPO Academy for Theranostics at
www.theranostics.academy (http://www.theranostics.academy)
Media contact ICPO Foundation
Susanne Simon
Head of Communication & Community
Email: susanne.simon@icpo.foundation (mailto:susanne.simon@icpo.foundation)
Phone: + 49 172 8666093
www.icpo.foundation (http://www.icpo.foundation)
Â